All In Biotech

Drug Trial Radar · NCT07227246

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial - Part 2

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

May 6, 2025

Primary completion

Jan 2029

Study completion Jun 2029

Sponsor

Lead sponsor
Joseph Broderick, MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); Japan Agency for Medical Research and Development; Novo Nordisk A/S
First posted
Nov 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 90 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy. FASTEST Part 2 is an extension of the FASTEST Trial where the subgroups include those treated within 2 hours with a positive spot sign on a baseline CT angiogram or patients treated within 90 minutes of stroke onset, with or without a positive spot sign.

Conditions

  • Intracerebral Hemorrhage

Interventions

  • Recombinant Factor VIIaBiological

    Participants will be randomized in a double-blinded fashion to rFVIIa 80 µg/kg dose (maximum 10 mg dose) or matching placebo. All participants in FASTEST Part 2 must have a positive spot sign on baseline CTA and be treated within 120 minutes of onset or patients treated within 90 minutes of stroke onset, with or without a positive spot sign. Participants in both arms will receive best standard therapy as per published AHA Guidelines for ICH, including a target systolic blood pressure of 140 mm Hg.

  • Biological/Vaccine: PlaceboBiological

    Participants will be randomized in a double-blinded fashion to rFVIIa 80 µg/kg dose (maximum 10 mg dose) or matching placebo. All participants in FASTEST Part 2 must have a positive spot sign on baseline CTA and be treated within 120 minutes of onset or patients treated within 90 minutes of stroke onset, with or without a positive spot sign. Participants in both arms will receive best standard therapy as per published AHA Guidelines for ICH, including a target systolic blood pressure of 140 mm Hg.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Modified Rankin ScaleTime frame: 90 days

Locations

88 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama Hospital

    Birmingham, Alabama · Recruiting

  • Kaiser Permanente Baldwin Park Medical Center

    Baldwin Park, California · Recruiting

  • Mills Peninsula Medical Center

    Burlingame, California · Recruiting

  • Kaiser Permanente Downey Medical Center

    Downey, California · Recruiting

  • Kaiser Permanente Fontana Medical Center

    Fontana, California · Recruiting

  • Kaiser Permanente South Bay Medical Center

    Harbor City, California · Recruiting

  • UCSD Health La Jolla

    La Jolla, California · Recruiting

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • Kaiser Permanente West Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California · Recruiting

  • UC Irvine Medical Center,

    Orange, California · Recruiting

  • Kaiser Permanente Riverside Medical Center

    Riverside, California · Recruiting

  • UC Davis Medical Center

    Sacramento, California · Recruiting

  • UCSD Medical Center - Hillcrest Hospital

    San Diego, California · Recruiting

  • San Francisco General Hospital

    San Francisco, California · Recruiting

  • UF Health Shands Hospital

    Gainesville, Florida · Recruiting

  • University of Florida Jacksonville (UF Health)

    Jacksonville, Florida · Recruiting

  • Mayo Clinic

    Jacksonville, Florida · Recruiting

  • Grady Memorial Hospital

    Atlanta, Georgia · Recruiting

  • WellStar Kennestone Hospital

    Marietta, Georgia · Recruiting

  • The Queen's Medical Center

    Honolulu, Hawaii · Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois · Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • Central DuPage Hospital

    Winfield, Illinois · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • UMass Memorial Medical Center

    Worcester, Massachusetts · Recruiting

  • Henry Ford Hospital

    Detroit, Michigan · Recruiting

  • M Health Fairview Ridges Hospital,

    Burnsville, Minnesota · Recruiting

  • M Health Fairview Southdale Hospital

    Edina, Minnesota · Recruiting

  • M Health Fairview St. John's Hospital

    Maplewood, Minnesota · Recruiting

  • M Health Fairview University of Minnesota Medical Center Hospital,

    Minneapolis, Minnesota · Recruiting

  • Mayo Clinic Saint Marys Campus

    Rochester, Minnesota · Recruiting

  • Barnes Jewish Hospital

    St Louis, Missouri · Recruiting

  • Mount Sinai West

    New York, New York · Recruiting

  • The Mount Sinai Hospital

    New York, New York · Recruiting

  • Stony Brook University Hospital

    Stony Brook, New York · Recruiting

  • University of Cincinnati Medical Center

    Cincinnati, Ohio · Recruiting

  • OSU Wexner Medical Center

    Columbus, Ohio · Recruiting

  • Riverside Methodist Hospital

    Columbus, Ohio · Recruiting

  • St. John Medical Center

    Tulsa, Oklahoma · Recruiting

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.